ZA971417B - Ibuprofen effervescent formulation and process for the preparation - Google Patents

Ibuprofen effervescent formulation and process for the preparation

Info

Publication number
ZA971417B
ZA971417B ZA971417A ZA971417A ZA971417B ZA 971417 B ZA971417 B ZA 971417B ZA 971417 A ZA971417 A ZA 971417A ZA 971417 A ZA971417 A ZA 971417A ZA 971417 B ZA971417 B ZA 971417B
Authority
ZA
South Africa
Prior art keywords
preparation
effervescent formulation
ibuprofen effervescent
ibuprofen
formulation
Prior art date
Application number
ZA971417A
Other languages
English (en)
Inventor
Peter Gruber
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Publication of ZA971417B publication Critical patent/ZA971417B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA971417A 1996-02-20 1997-02-19 Ibuprofen effervescent formulation and process for the preparation ZA971417B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19606151A DE19606151C2 (de) 1996-02-20 1996-02-20 Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben

Publications (1)

Publication Number Publication Date
ZA971417B true ZA971417B (en) 1998-07-28

Family

ID=7785823

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA971417A ZA971417B (en) 1996-02-20 1997-02-19 Ibuprofen effervescent formulation and process for the preparation

Country Status (6)

Country Link
US (1) US6171617B1 (fr)
EP (1) EP0877606B1 (fr)
AU (1) AU1792597A (fr)
DE (2) DE19606151C2 (fr)
WO (1) WO1997030698A1 (fr)
ZA (1) ZA971417B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
CA2549642C (fr) * 2003-12-31 2012-10-30 Cima Labs Inc. Formes galeniques d'opiates orales effervescentes et procedes d'administration d'opiates
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
DE602004031462D1 (de) * 2003-12-31 2011-03-31 Cima Labs Inc Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
EP1750677B1 (fr) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Systeme d'administration orale de compose therapeutique
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CN101175485B (zh) * 2005-03-22 2012-03-07 洛桑药物有限公司 增溶的布洛芬
EP1800667A1 (fr) 2005-12-23 2007-06-27 Losan Pharma GmbH Granulate d'ibuprofen solubilisé rapidement
EP2559430B1 (fr) * 2005-03-22 2015-06-24 Losan Pharma GmbH Ibuprofen solubilisé
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US9757455B2 (en) * 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
EP1905428A1 (fr) * 2006-09-26 2008-04-02 Losan Pharma GmbH Comprimé effervescent d'une désintégration rapide et procès pour la preparation
EP1905427B1 (fr) * 2006-09-28 2010-11-24 Losan Pharma GmbH Formulation solubilisée rapidement des anti-inflammatoires non stéroïdiens
NZ624922A (en) 2009-10-01 2016-05-27 Adare Pharmaceuticals Inc Orally administered corticosteroid compositions
WO2015034678A2 (fr) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles
ES2612238T3 (es) 2014-02-27 2017-05-12 Galenicum Health S.L. Composiciones farmacéuticas estables
JP6532153B2 (ja) * 2015-01-30 2019-06-19 ライオン株式会社 内服用錠剤
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759520A (fr) 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
US4414198A (en) 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
DE3440288C2 (de) 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
JPH0830005B2 (ja) 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
CH677606A5 (fr) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
CH684929A5 (de) * 1992-11-19 1995-02-15 Sipharm Sisseln Ag Ibuprofen-haltige Brausezusammensetzung und ihre Herstellung.
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
EP0667149A1 (fr) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Composition effervescente d'ibuprofène
EP0673644A1 (fr) * 1994-03-18 1995-09-27 E-PHARMA TRENTO S.p.A. Procédé et appareillage pour la production de granulés effervescents

Also Published As

Publication number Publication date
US6171617B1 (en) 2001-01-09
WO1997030698A1 (fr) 1997-08-28
EP0877606A1 (fr) 1998-11-18
AU1792597A (en) 1997-09-10
EP0877606B1 (fr) 2000-09-13
DE59702346D1 (de) 2000-10-19
DE19606151C2 (de) 1999-05-12
DE19606151A1 (de) 1997-08-21

Similar Documents

Publication Publication Date Title
ZA971417B (en) Ibuprofen effervescent formulation and process for the preparation
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
ZA974486B (en) Concentrated antibody formulation
GB9900156D0 (en) Erythromycins and process for the preparation
HUP9900330A3 (en) Pyrrolopyrimidines and processes for the preparation thereof
HUP9901454A3 (en) Dosage form of ibuprofen
GB9715490D0 (en) Pharmaceutical preparation
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
EP0926154A4 (fr) Nouveaux oligosaccharides a base de lactosamine et procede de preparation
HUP0000125A3 (en) Liquid alendronate formulations and producing them
GB2307857B (en) An effervescent formulation
GB9615628D0 (en) Formulation
IL122068A0 (en) Aspartame and process for the preparation thereof
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
GB9404989D0 (en) Lipomimetric formulation
HUP9601520A2 (en) Substituted quinoline-intermediates and process for preparation the same
HU9602732D0 (en) Lanperisone formulation
GB9603141D0 (en) Pharmaceutical formulation
GB9613183D0 (en) Effervescent alendronate formulation
GB9621749D0 (en) Pharmaceutical combination formulation
GB9412395D0 (en) Pharmaceutical formulation
GB9425074D0 (en) Pharmaceutical formulation